{"_id":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgJD4276rCAw","type":"Investor","logokey":"$1t9x1LqdbnyChesHXq3HOxaJPzWUAc5PCzbDV5JZE1JnwT5Ijv880q","name":"Foresite Capital","subtype":"VC and Private Equity","lastupdate":"2022-06-14T00:00:00.000Z","update_date":"2022-06-14T00:00:00.000Z","lastModified":"Aug 18, 2024","active":1,"confidence_score":34,"confidence_score_reason":"product stage, sector, number of employees, tags, invite member, business model, tag line, homepage, video or image, funding rounds, markets, not claimed","urlname":"foresite-capital","minimal_profile":1,"hide_reason":null,"status":"Active","fullstatus":"Active","hide_reason_data":null,"acquired":null,"description_edited":null,"tag_line_edited":null,"isisraeli":0,"country":"United States","formernames":[],"min_date_investments":"2022-01-01T00:00:00.000Z","hide_reasons":[{"id":"71DetFrndkNwNZufhli91PBqJkgDvyWv0skK3yYHYitL6RnFpb2Uf1","reason":"Pending approval - External entity"},{"id":"bMlvNZGgO393OpCQn2LLGyGQIyzd4aZiwm516IvRMWEx6Fkam4LPsQ","reason":"Firm does not match any of Finder’s investors entities"},{"id":"hUspihf43qDmsZbgaEhZKEfAAW3v31Vgv8cpxJzOvLRPPTJ0F4MHzR","reason":"Pending approval"},{"id":"o9Wzo8oG7DIeZVpiC2CdK6IVPWAA4wFvEE97ITVY0oHo6HyeP4v2YV","reason":"Firm asked to delete"},{"id":"rW7l4bkGn6inVBM54t8wGMz9mlLAxGGZOgTQSofPoEagmlofSfwSil","reason":"Foreign, no presence - no Israeli investments/fund"},{"id":"TW4W1IZcqaOGz6jCahuX2wE03SdSzw54lheysaeW0zOAsmOGBFF014","reason":"Foreign, no presence - not enough investments"},{"id":"wcXeLKSl465vLdJtWXjddE1UVQbANeL8NjdsDpAh0CYTtOJw8wHP97","reason":"Firm asked to hide in the meantime"}],"registrar":null,"founded_year":2010,"iia_supported":null,"currently_iia_supported":null,"alternativenames":null,"managedassets":"Undisclosed","representing":null,"supported_by":"","supported_by_id":"","inisraelsince":"","inisraelsincemonth":"","investment_lower_amount":null,"investment_upper_amount":null,"marketcapital":null,"marketcapitaldate":null,"oneliner":"","website":"","sociallinks":{"twitter":"","youtube":"","facebook":"","linkedin":"https://www.linkedin.com/company/1451892","instagram":""},"social":["https://www.linkedin.com/company/1451892"],"flattenedsociallinks":"https://www.linkedin.com/company/1451892","apps":{"appstore":"","googleplay":""},"investmentstage":[],"about":"Foresite Capital is a multi-stage healthcare and life sciences investment firm with ~ $3.5B in assets under management (as of 12/31/23). The firm aims to address areas of great unmet need by funding promising healthcare and life sciences businesses at all stages of their life cycles. Foresite Capital uses a data science-driven approach to invest in companies that leverage biology and big data to transform healthcare, including 10x Genomics, Relay Therapeutics, Element Biosciences, Inscripta, as well as companies developing next generation therapeutics. Founded in 2011, Foresite Capital is based in San Francisco.","founded":"12/2010","education":null,"additional_activities":null,"techcommunityinvolvement":null,"exits":[{"date":"Oct 2024","batch":null,"token":null,"amount":"Undisclosed","isexit":1,"eventid":"4rKxIkt5yzd2zEMOOxnocer2uw2GylB4os1ySXJ6al6ba3nXaWubwA","mnatype":"Acquisition","eventtype":"MNAEvent","valuation":"Undisclosed","wasacquired":1,"capitalraised":"Undisclosed","stockexchange":null,"eventvisibility":"Public","token_visibility":"","acquiredcompany_mna":"ImmPACT Bio","acquiredcompany_spac":null,"acquiringcompany_mna":"Lyell Immunopharma","stockexchange_logokey":null,"acquiredcompany_mna_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoPH9tMALDA","acquiredcompany_reverse":null,"acquiredcompany_spac_id":null,"acquiringcompany_mna_id":"6W86QKe40FccULsEmKiz54HcTvvVHT3EY44IRgbILOpwV4wz5EAvPo","acquiredcompany_mna_hidden":0,"acquiredcompany_reverse_id":null,"acquiredcompany_mna_fullurl":"/company_page/immpact-bio","acquiredcompany_mna_logokey":"$3p73CkjSNEmQu8LgGFlmc6xpIulpBCVUZki53yQExPwplQjpKKvKXP","acquiredcompany_mna_urlname":"immpact-bio","acquiredcompany_spac_hidden":null,"acquiringcompany_mna_hidden":1,"acquiredcompany_spac_fullurl":null,"acquiredcompany_spac_logokey":null,"acquiredcompany_spac_urlname":null,"acquiringcompany_mna_fullurl":"/mnc_page/lyell-immunopharma","acquiringcompany_mna_logokey":"$rSWeI6Y00ziAGrFGd6Y3S49F0XKjSAT35P3PgYtxcB18CtHLjm98aV.png","acquiringcompany_mna_urlname":"lyell-immunopharma","acquiredcompany_reverse_hidden":null,"acquiredcompany_reverse_fullurl":null,"acquiredcompany_reverse_logokey":null,"acquiredcompany_reverse_urlname":null,"blurFinancialData":"","stockexchange_logourl":"/assets/empty-state.svg","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$3p73CkjSNEmQu8LgGFlmc6xpIulpBCVUZki53yQExPwplQjpKKvKXP","acquiredcompany_spac_logourl":"/assets/empty-state.svg","acquiringcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$rSWeI6Y00ziAGrFGd6Y3S49F0XKjSAT35P3PgYtxcB18CtHLjm98aV.png","acquiredcompany_reverse_logourl":"/assets/empty-state.svg","acquiringcompany_style":"","acquiringcompany_hiddenCompanyTooltip":"","style":"","hiddenCompanyTooltip":""}],"funds":[{"date":"Jun 2024","name":"Life Sciences","title":"Fund Life Sciences","amount":"$900M","source":"https://www.wsj.com/articles/foresite-capital-closes-900-million-life-sciences-venture-fund-17b94a8b","eventid":"pZsL7bqxHRtOat2ZbCDT3p5IDWk0ZK7P9wVuJ5alZkcHl3Bu3Certl","visibilitytype":"Public","amountvisibility":"Public","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":""}],"portfolio":[{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoPH9tMALDA","name":"ImmPACT Bio","hidden":false,"raised":"$137M","founded":"2017","fullurl":"/company_page/immpact-bio","logokey":"$3p73CkjSNEmQu8LgGFlmc6xpIulpBCVUZki53yQExPwplQjpKKvKXP","urlname":"immpact-bio","employees":"11-50","description":"CAR-T Cell Therapies for Treating Cancer","fundingstage":"Acquired","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":137000000,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$3p73CkjSNEmQu8LgGFlmc6xpIulpBCVUZki53yQExPwplQjpKKvKXP","style":"","hiddenCompanyTooltip":""}],"investments":[{"date":"Jan 2022","name":"ImmPACT Bio","amount":111000000,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgJDE9NTNCAw","fullurl":"/company_page/immpact-bio","logokey":"$3p73CkjSNEmQu8LgGFlmc6xpIulpBCVUZki53yQExPwplQjpKKvKXP","tagline":"CAR-T Cell Therapies for Treating Cancer","urlname":"/company_page/immpact-bio","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoPH9tMALDA","isfollowon":0,"companytype":"Startup","eventamount":"$111M","fundingtype":"B Round","investmentid":"ea5bbd95-3bd5-41d5-89e4-05875538b173","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$3p73CkjSNEmQu8LgGFlmc6xpIulpBCVUZki53yQExPwplQjpKKvKXP","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""}],"team":[],"tags":[],"targetmarkets":[],"phone":null,"address":{"israeli":[],"officesabroad":[{"id":"C9WuuBXxUWM3HOLHXKn67cKRgXnt4k6KuoT1ht4CoCQQWpdDYDPSBf","city":"Los Angeles","address":"Los Angeles, CA, USA","country":"United States","placeid":"ChIJE9on3F3HwoAR9AhGJW_fL-I"},{"id":"eoLYn5fkUjev2swiElw5C0Y1oAk5vKqs8EozoKAEQWwzR2HtVTlKaY","city":"New York","address":"New York, NY, USA","country":"United States","placeid":"ChIJOwg_06VPwokRYv534QaPC8g"},{"id":"iJ3VirjhYqNOL73NbiuEPrtgrHydnpfhp4GGwr6ufGL6RKj70lJX0n","city":"San Francisco","address":"San Francisco, CA, USA","country":"United States","placeid":"ChIJIQBpAG2ahYAR_6128GcTUEo"}]},"headquarter_address":null,"news":[{"id":"AWbp3lY9PAd1lF4RqhTp6W7cNaklaxiduDb8wxw5uQIOuPSDtng48D","date":"Jun 12, 2024","link":"https://www.wsj.com/articles/foresite-capital-closes-900-million-life-sciences-venture-fund-17b94a8b?mod=tech_lead_pos2","source":"www.wsj.com","visible":1,"analysis":null,"sentiment":null,"analysisId":"n7VtUv41JReaClLLCE5WGGTmJffxr24wiyHuHEBdhSHqSDEVVrsMSh","news_summary":"Foresite Capital Closes $900 Million Life Sciences Venture Fund","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"none"}],"newsNumber":1,"mediagallery":[],"biverification":null,"sectorverify":null,"biverify":null,"biverifydate":null,"crunchbaseid":null,"lastupdator":null,"lastupdator_email":null,"creator":"Yotam Maman","creator_email":"yotamm1988@gmail.com","createdate":"2022-01-20T00:00:00.000Z","recentupdates":[{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-06-13 07:13:33.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Automatic","datetime":"2024-08-18 07:12:03.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-06-13 07:13:33.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-06-13 07:13:33.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-08-18 07:12:02.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-06-13 07:13:34.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Automatic","datetime":"2024-08-18 07:12:03.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Automatic","datetime":"2024-08-18 07:12:03.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-06-13 07:13:37.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-06-13 07:13:35.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-06-13 07:13:33.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-06-13 07:13:35.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-06-13 07:13:33.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Automatic","datetime":"2024-08-18 07:12:05.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Automatic","datetime":"2024-06-13 07:13:37.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Automatic","datetime":"2024-08-18 07:12:05.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Automatic","datetime":"2024-06-13 07:13:37.000000","last_name":"Wein","first_name":"Ortal"}],"rounds_per_sector":[{"count":1,"sector":"Health Tech & Life Sciences"}],"rounds_per_stage":[{"count":1,"isfollowon":0,"fundingStage":"B Round"}],"investment_rounds_over_time":[{"year":2022,"month":1,"record_count":1}],"portfolio_companies_per_sector":[{"count":1,"sector":"Health Tech & Life Sciences"}],"new_portfolio_companies_over_time":[{"year":2022,"month":1,"record_count":1}],"exits_over_time":[{"year":2024,"count":1,"eventType":"MNAEvent"}],"exits_by_sector":[{"count":1,"sector":"Health Tech & Life Sciences"}],"affiliatedOrganizations":null,"timeline":[{"id":"pZsL7bqxHRtOat2ZbCDT3p5IDWk0ZK7P9wVuJ5alZkcHl3Bu3Certl","date":"2024-06-01","name":"Life Sciences","title":"Fund Life Sciences","amount":900000000,"source":"https://www.wsj.com/articles/foresite-capital-closes-900-million-life-sciences-venture-fund-17b94a8b","eventtype":"InvestmentFirmFundingEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"style":"","hiddenCompanyTooltip":""}],"databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"VC and Private Equity","parsedName":"Foresite Capital","logourl":"https://storage.googleapis.com/clean-finder-353810/$1t9x1LqdbnyChesHXq3HOxaJPzWUAc5PCzbDV5JZE1JnwT5Ijv880q","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$1t9x1LqdbnyChesHXq3HOxaJPzWUAc5PCzbDV5JZE1JnwT5Ijv880q","teamMembersNumber":0,"section":null,"sectionParams":"","queryParams":"","seoabout":"Foresite Capital is a multi-stage healthcare and life sciences investment firm with ~ $3.5B in assets under management (as of 12/31/23). The firm aims to a...","seoTitle":"Foreign VC and Private Equity","serializedCharts":"{\"investmentsRoundsByRoundType\":[{\"fundingStage\":\"B Round\",\"newInvestments\":1,\"followOnInvestments\":0}],\"investmentRoundsBySector\":[{\"count\":1,\"sector\":\"Health Tech & Life Sciences\"}],\"investmentRoundsOverTime\":[{\"label\":\"2022\",\"count\":1},{\"label\":\"2023\",\"count\":0},{\"label\":\"2024\",\"count\":0},{\"label\":\"2025\",\"count\":0},{\"label\":\"2026\",\"count\":0}],\"portfolioCompaniesBySector\":[{\"count\":1,\"sector\":\"Health Tech & Life Sciences\"}],\"portfolioCompaniesOverTime\":[{\"label\":\"2022\",\"count\":1},{\"label\":\"2023\",\"count\":0},{\"label\":\"2024\",\"count\":0},{\"label\":\"2025\",\"count\":0},{\"label\":\"2026\",\"count\":0}],\"exitsOverTime\":[{\"year\":2024,\"count\":1,\"eventType\":\"MNAEvent\"},{\"year\":2022,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2022,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2023,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2023,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2025,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2025,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2026,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2026,\"count\":0,\"eventType\":\"publicExits\"}],\"exitsBySector\":[{\"count\":1,\"sector\":\"Health Tech & Life Sciences\"}]}","statusinfo":"","iiasupport":"","managedAssetsNumber":null,"investmentrange":"$111M - $111M","communityinvolvement":[],"foreignInvestments":"","nationality":"Foreign","investorStatistics":{"exitRatio":{"amount":"0"},"investmentFollowOnRatio":{"amount":""},"leadInvestorShare":{"amount":"0"},"soloInvestmentRoundRatio":{"amount":"0"},"firstInvestorRatio":{"amount":"0"}},"popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none"},"mainContact":{}}